WeRide has posted six weeks of steady short covering alongside a 14% one-month price recovery, creating a notable divergence between where the bears were and where the lending market stands today.
The most striking shift in WRD's positioning is the pace of short covering. Short interest has fallen roughly 30% over the past month — from around 16.6 million shares at the start of July to 11.6 million now, representing 3.4% of the free float. That's a meaningful unwind for a stock at this price level, and it coincides directly with the stock's climb from the low-$5 range toward $6.33. The borrow market reflects the easing too: cost to borrow is running near 1.2%, essentially flat over the month, and well within the range of a stock that's easy and cheap to short. Availability has loosened noticeably this week to around 49% — still on the tighter end of the scale, but a material improvement from the near-fully-lent readings of late July and early August, when availability briefly touched 22%. The 52-week low availability of 19% was recorded on July 13, when short interest was also near its peak. The directional logic is clean: as shorts covered, more lendable supply returned to the pool.
Options traders are not hedging against any further rally. The put/call ratio is running at 0.17, below its 20-day average of 0.19 and approaching the 52-week low of 0.14. That's nearly one standard deviation below the recent norm — a setup that reflects call-dominant positioning, consistent with investors reaching for upside rather than protecting against downside. The contrast with mid-July, when the PCR was above 0.25, is stark. Whatever nervousness drove that defensive positioning has largely unwound alongside the short interest.
The Street picture for WRD is complicated by the gap between analyst targets and current prices. All available initiations carry Buy-equivalent ratings — HSBC, B of A Securities, Citi, UBS, JP Morgan, and Morgan Stanley all launched coverage with bullish calls, with targets ranging from $11 to $23. At $6.33, the stock trades at a significant discount to even the most conservative of those targets. However, the most recent initiation was HSBC's at $11 in late March 2026, and the earliest coverage predates the current trading range by well over a year — so these targets should be read as directional signals rather than precise marks. The ORTEX short score of 60 places WRD in moderate short-squeeze territory, though the score has been drifting lower over the past ten days as covering activity eased some of the technical pressure. The price-to-book multiple has risen around 0.28 turns over the past month, the clearest valuation signal of the stock's recovery.
Institutional ownership tells a nuanced story. Morgan Stanley Investment Management added roughly 8.9 million shares as of mid-April, now holding 4.2% of the company — a position that, combined with the firm's own broker-dealer stake of 1.3%, makes Morgan Stanley one of the largest institutional presences. On the other side, Uber Technologies trimmed its position by over 11 million shares to 7.6 million, reducing its stake to 2.3%. Uber's cut is worth noting: as an early strategic partner and investor, a reduction of that scale could reflect portfolio rebalancing rather than a fundamental view change, but it removes a high-profile name from the supportive shareholder base. The one flagged insider transaction — a 5% shareholder buying $11.8 million worth of shares in late March at $2.49 — is now stale at 139 days old, though the implied conviction at that price is worth contextualising against today's $6.33 level.
Earnings is the immediate catalyst. WRD reported today — August 12 — with results announced mid-session. The only prior reaction in the data is a small 0.14% one-day decline following the May 22 print, followed by a 2.3% gain over the subsequent five days, suggesting the market absorbed that quarter without much drama. What to watch in the aftermath is whether the short covering that drove the last month's move accelerates further on any positive revenue commentary, or whether availability tightens again as fresh shorts re-enter on any signs of a slowing commercialisation timeline.
See the live data behind this article on ORTEX.
Open WRD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
